Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Breast cancer metastatic Trials in Disease

36 / 84 trials open to patients22 countries

Clinical trials for Breast cancer metastatic

Recruiting trials first

See all 84 trials →
Quick filters

84 clinical trials in this condition

Breast cancer+1

Recruiting

Maintenance Therapy Study of Inavolisib with Pertuzumab and Trastuzumab in Patients with HER2‑Positive, PIK3CA‑Mutated Locally Advanced or Metastatic Breast Cancer

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:F. Hoffmann-La Roche AG

Breast cancer metastatic

Recruiting

A study of palazestrant and ribociclib compared to letrozole and ribociclib for patients with advanced ER+ HER2- breast cancer

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Letrozole
  • Sponsor:Olema Pharmaceuticals Inc.

Breast cancer metastatic

Recruiting

Phase 1b-2 Study of Elacestrant and Abemaciclib in Patients with Brain Metastases from ER-Positive, HER2-Negative Breast Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Stemline Therapeutics Inc.

Breast cancer+1

Recruiting

Study of inavolisib and fulvestrant for patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Fulvestrant
  • Sponsor:F. Hoffmann-La Roche AG
See all 84 trials →filters applied: condition = Breast cancer metastatic

About the disease

What patients should know

This article provides information about ongoing clinical trials for metastatic breast cancer, a condition where breast cancer has spread beyond the breast to other parts of the body. These studies are testing new treatments and combinations of medications to improve outcomes for patients with different types of metastatic breast cancer, including hormone receptor-positive, HER2-positive, and triple-negative breast cancer. (Also known as: Stage IV Breast Cancer, Advanced Breast Cancer)

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Related conditions in the same therapeutic area

Breast cancer 170Triple negative breast cancer 69Hormone receptor positive HER2 negative breast cancer 62HER2 positive breast cancer 42Hormone receptor positive breast cancer 42Breast cancer female 27Ovarian cancer 19Non-small cell lung cancer 16Endometrial cancer 11HER2 negative breast cancer 10Colorectal cancer 9Gastric cancer 9Breast cancer stage III 8Human epidermal growth factor receptor negative 8Oesophageal adenocarcinoma 8
Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.